205 related articles for article (PubMed ID: 19534821)
21. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
[TBL] [Abstract][Full Text] [Related]
22. In vivo bioluminescence visualization of antitumor effects by human MUC1 vaccination.
Jeon YH; Choi Y; Kim HJ; Kang JH; Kim CW; Jeong JM; Lee DS; Chung JK
Mol Imaging; 2007; 6(5):297-303. PubMed ID: 18092514
[TBL] [Abstract][Full Text] [Related]
23. A unique MUC1-2-VNTR DNA vaccine suppresses tumor growth and prolongs survival in a murine multiple myeloma model.
Weng Y; Shao L; Ouyang H; Liu Y; Yao J; Yang H; Luo Y; Wang H; Zhao Z; Mou H; Zhou Z; Zhang Y
Oncol Rep; 2012 Jun; 27(6):1815-22. PubMed ID: 22407148
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and efficacy of a DNA vaccine encoding a human anti-idiotype single chain antibody against nasopharyngeal carcinoma.
Luo C; Wang JJ; Li YH; Hu JY; Li GC
Vaccine; 2010 Mar; 28(15):2769-74. PubMed ID: 20117260
[TBL] [Abstract][Full Text] [Related]
25. Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model.
Kontani K; Taguchi O; Ozaki Y; Hanaoka J; Tezuka N; Sawai S; Inoue S; Fujino S; Maeda T; Itoh Y; Ogasawara K; Sato H; Ohkubo I; Kudo T
Cancer Gene Ther; 2002 Apr; 9(4):330-7. PubMed ID: 11960283
[TBL] [Abstract][Full Text] [Related]
26. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
[TBL] [Abstract][Full Text] [Related]
27. Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred.
Mukherjee P; Ginardi AR; Madsen CS; Sterner CJ; Adriance MC; Tevethia MJ; Gendler SJ
J Immunol; 2000 Sep; 165(6):3451-60. PubMed ID: 10975866
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer.
Guo M; Luo B; Pan M; Li M; Xu H; Zhao F; Dou J
Int Immunopharmacol; 2020 Nov; 88():106850. PubMed ID: 32777675
[TBL] [Abstract][Full Text] [Related]
29. CEA Plasmid as Therapeutic DNA Vaccination against Colorectal Cancer.
Veisi Malekshahi Z; Hashemi Goradel N; Shakouri Khomartash M; Maleksabet A; Kadkhodazadeh M; Kardar GA; Negahdari B
Iran J Immunol; 2019 Sep; 16(3):235-245. PubMed ID: 31552832
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of anti-tumor effect of plasmid DNA-carrying MUC1 by the adjuvanticity of FLT3L in mouse model.
Gao FS; Zhan YT; Wang XD; Zhang C
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):353-357. PubMed ID: 30111221
[TBL] [Abstract][Full Text] [Related]
31. MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines.
Acres B; Apostolopoulos V; Balloul JM; Wreschner D; Xing PX; Ali-Hadji D; Bizouarne N; Kieny MP; McKenzie IF
Cancer Immunol Immunother; 2000 Jan; 48(10):588-94. PubMed ID: 10630311
[TBL] [Abstract][Full Text] [Related]
32. [MUC1-2VNTR DNA Vaccine Induces Immune Responses in Mouse Model with Multiple Myeloma].
Liu YB; Zhou ZP; Wang H; Yang H; Mu H; Huang GY; Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1366-9. PubMed ID: 26524039
[TBL] [Abstract][Full Text] [Related]
33. Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer.
Mukherjee P; Madsen CS; Ginardi AR; Tinder TL; Jacobs F; Parker J; Agrawal B; Longenecker BM; Gendler SJ
J Immunother; 2003; 26(1):47-62. PubMed ID: 12514429
[TBL] [Abstract][Full Text] [Related]
34. Effective anti-tumor responses induced by recombinant bacillus Calmette-Guérin vaccines based on different tandem repeats of MUC1 and GM-CSF.
Yuan S; Shi C; Han W; Ling R; Li N; Wang T
Eur J Cancer Prev; 2009 Sep; 18(5):416-23. PubMed ID: 19550341
[TBL] [Abstract][Full Text] [Related]
35. Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors.
Mehla K; Tremayne J; Grunkemeyer JA; O'Connell KA; Steele MM; Caffrey TC; Zhu X; Yu F; Singh PK; Schultes BC; Madiyalakan R; Nicodemus CF; Hollingsworth MA
Cancer Immunol Immunother; 2018 Mar; 67(3):445-457. PubMed ID: 29204701
[TBL] [Abstract][Full Text] [Related]
36. MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral.
Apostolopoulos V; Osinski C; McKenzie IF
Nat Med; 1998 Mar; 4(3):315-20. PubMed ID: 9500605
[TBL] [Abstract][Full Text] [Related]
37. Immunization with two recombinant Bacillus Calmette-Guérin vaccines that combine the expression of multiple tandem repeats of mucin-1 and colony stimulating-factor suppress breast tumor growth in mice.
Yuan S; Shi C; Ling R; Wang T; Wang H; Han W
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1359-67. PubMed ID: 20127358
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen.
Hillman GG; Reich LA; Rothstein SE; Abernathy LM; Fountain MD; Hankerd K; Yunker CK; Rakowski JT; Quemeneur E; Slos P
J Immunother Cancer; 2017; 5():4. PubMed ID: 28116088
[TBL] [Abstract][Full Text] [Related]
39. [Construction of a DNA vaccine against extracellular domain 1-3 of Flk1 and its inhibitory effect on growth of liver cancer cell line H22].
Lu F; Qin ZY; Li YM; Qi YX; Liu YF; Yang WB
Ai Zheng; 2004 Dec; 23(12):1616-21. PubMed ID: 15601548
[TBL] [Abstract][Full Text] [Related]
40. Intradermal vaccination of MUC1 transgenic mice with MUC1/IL-18 plasmid DNA suppresses experimental pulmonary metastases.
Shi FF; Gunn GR; Snyder LA; Goletz TJ
Vaccine; 2007 Apr; 25(17):3338-46. PubMed ID: 17292519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
